|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2002-2-6
|
|
pubmed:abstractText |
We studied the clinical effect of recombinant human erythropoietin (r-huEPO) on anemia induced by two courses of cisplatin-based chemotherapy in patients with non-small cell lung cancer (NSCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1341-9625
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
296-301
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11828949-Anemia,
pubmed-meshheading:11828949-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11828949-Blood Transfusion,
pubmed-meshheading:11828949-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:11828949-Cisplatin,
pubmed-meshheading:11828949-Double-Blind Method,
pubmed-meshheading:11828949-Drug Administration Schedule,
pubmed-meshheading:11828949-Erythropoietin,
pubmed-meshheading:11828949-Female,
pubmed-meshheading:11828949-Hemoglobins,
pubmed-meshheading:11828949-Humans,
pubmed-meshheading:11828949-Lung Neoplasms,
pubmed-meshheading:11828949-Male,
pubmed-meshheading:11828949-Middle Aged,
pubmed-meshheading:11828949-Mitomycin,
pubmed-meshheading:11828949-Recombinant Proteins,
pubmed-meshheading:11828949-Treatment Outcome,
pubmed-meshheading:11828949-Vindesine
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer.
|
|
pubmed:affiliation |
Department of Respiratory Medicine, Yokohama Municipal Citizen's Hospital, 56 Okazawa-cho, Hodogaya-ku, Yokohama 240-8555, Japan. kunikane@courante.plala.or.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
